Shopping Cart
Remove All
Your shopping cart is currently empty
Ubamatamab (REGN4018), a human bispecific antibody targeting Mucin 16 (MUC16) and CD3, exhibits potent antitumor activity [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $790 | - | In Stock | |
| 5 mg | $2,280 | - | In Stock | |
| 10 mg | $3,600 | 2-4 weeks | 2-4 weeks |
| Description | Ubamatamab (REGN4018), a human bispecific antibody targeting Mucin 16 (MUC16) and CD3, exhibits potent antitumor activity [1]. |
| Reactivity | Human |
| Verified Activity | OVCAR-3 cells at 1×10^5 cells/well can bind Ubamatamab. The EC50 is 0.421 nM.
huCD3e-Jurkat cells at 1×10^5 cells/well can bind Ubamatamab. The EC50 is 15.06 nM. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD3E & MUC16 |
| Molecular Weight | 144.64 kDa |
| Cas No. | 2305629-50-7 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | 05 | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.